김태완
Kim, Tae Wan학력
- 2009 ~ 2014서울대학교 박사
- 2005 ~ 2007서울대학교 석사
- 1998 ~ 2005아주대학교 학사
경력
- 2015 ~ 2023Memorial Sloan Kettering Cancer Center / Senior Research Scientist
- 2014 ~ 2015서울대학교 / 연수연구원
- 2008 ~ 2008국립암센터 / 연구원
수상실적
- 2025 총장표창 / DGIST
- 2014 Sanofi Young Scientist Award / 한국생화학분자생물학회
- 2014 우수졸업상 / 서울대학교(연건캠퍼스)
- 2010 The 11th Seoul Science Fellowship / 서울특별시
연구실 소개
- Stem Cell Engineering / Therapy Lab
-
Our lab utilize human stem cells to understand human development and degeneration. It aims to develop novel stem cell-based theurapeutics in incurable disease, such as neurodegenerative disorder.
Research Interests
Related Keyword
- "Human stem cell-based cell replacement therapy for Parkinson's disease: Enhancing the survival of postmitotic dopamine neuron grafts", Neural Regeneration Research, v.21, no.2, pp.689 - 690
- "Phosphorylation-mediated disassembly of C-terminal binding protein 2 tetramer impedes epigenetic silencing of pluripotency in mouse embryonic stem cells", Lee, Han-Teo. (2024-11). Phosphorylation-mediated disassembly of C-terminal binding protein 2 tetramer impedes epigenetic silencing of pluripotency in mouse embryonic stem cells. Nucleic Acids Research, 52(22), 13706–13722. doi: 10.1093/nar/gkae1076
- "TNF-NF-κB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons", Kim, Tae Wan. (2024-07). TNF-NF-κB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons. Cell, 187(14), 3671-3689.e23. doi: 10.1016/j.cell.2024.05.030
연구 뉴스
연구분야
미래유망 신기술(6T)
국가과학기술표준분류